
Introduction to the CosMx Webinar series and “The single-cell spatial revolution: CosMx SMI”
View On Demand
Abstract
Single-cell Giant Leaps
Insights obtained from single-cell analysis are critically important to better understand how disease starts, progresses, and responds to therapy. But when it comes to the world of a cell, spatial context matters. What kind of cell are you? How do you interact with your neighbors? What’s in your cellular neighborhood?
The CosMx Spatial Molecular Imager (SMI) gives you a clear picture of the cellular environment in tissue sections that is sorely lacking from single-cell genomics, where cells are dissociated from their neighborhoods.
Come with us on a journey into the neighborhoods of single cells with a webinar series featuring ten leading researchers who are using CosMx SMI to gain deeper insights into cellular and subcellular gene and protein expression. The opening session gives an interactive overview of CosMx SMI and how it works.
Learn from researchers who are key opinion leaders in their fields of immunology, oncology, and infectious disease about how cell atlasing, cell state and neighborhood/niche analysis, and cell-cell interaction mapping can take translational research to even higher levels of precision.
Explore the limitless possibilities with the highest-plex RNA offering and layer on spatial proteomics to uncover the intricacies of events occurring within and around single cells.
Speaker

Vikram Devgan, PhD
Senior Director, Product Management, NanoString
Vikram Devgan, PhD, MBA is a Senior Director of the Spatial Genomics Business Unit at NanoString. Prior to joining NanoString, Dr. Devgan held positions of increasing responsibilities with the National Cancer Institute (NCI) and QIAGEN Inc., including the Chief of Clinical Grants and Contracts Branch of the Cancer Therapy Evaluation Program (CTEP) at NCI and the Head of Biological Research Content Business at QIAGEN. Dr. Devgan has extensive experience in genomics, particularly spatial biology. Dr. Devgan received his Ph.D. in molecular and cellular biology and conducted post-doctoral research at the Harvard Medical School, Massachusetts. He also holds an MBA in Business Integration from the University of Wurzburg, Germany.